Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

3D Printing – A Brave New World For Pharma And Patents

This article was originally published in Scrip

Executive Summary

In the same way that railways and fast broadband access changed the rules on where businesses could operate from, so too will 3D printing change the manufacturing and distribution of tomorrow. It presents enormous opportunity for small and medium businesses and perhaps a chance for manufacturing to return on a larger scale in the most developed economies. The accessibility of 3D printing promises to empower both businesses and individuals to create products which under traditional manufacturing processes would have been prohibitive both in terms of cost and logistics. For businesses of all sizes, the potential to decentralize production holds exciting opportunities. With the first regulatory approval of a 3D printed prescription drug, a world of opportunity presents itself for innovative pharmaceutical companies. However, capitalizing on 3D printing technology whilst retaining control over intellectual property rights (IPRs) will be challenging and require a rethink of traditional approaches both to patent drafting and licensing.

Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC029970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel